Skip to main content

Actor Shreyas Talpade suffers heart attack

Actor Shreyas Talpade, aged 47, experienced a heart attack shortly after wrapping up a film shoot on Thursday evening. Following the incident, he was swiftly taken to an Andheri hospital, where he underwent angioplasty. The actor's family instructed the medical staff not to disclose specific details regarding his condition or the treatment administered. Talpade had been working on the film 'Welcome to the Jungle.' Throughout the day, he reportedly filmed various scenes, including minor action sequences, and was observed to be in good spirits, laughing, and joking on the set, according to unit members.

from Times of India https://ift.tt/8vhftHO
via

Comments

Popular posts from this blog

Wet spell likely in north & central India till Jan 9: IMD

The India Meteorological Department (IMD) on Wednesday predicted a wet spell over northwest India, including Delhi-NCR, Punjab and Haryana, and central India till January 9 due to two consecutive active western disturbances. It, however, said that there may not be cold wave conditions over north India during the next five days. from Times of India https://ift.tt/34pJ29g via

Kashmiri Pandit killed in J&K's Shopian, 7th since 2020

A terrorist shot dead 43-year-old Kashmiri Pandit farmer Puran Krishan Bhat outside his home in Choudharygund village of south Kashmir’s Shopian district Saturday morning, triggering protests in Jammu against the latest targeted attack on the community. DIG Sujit Kumar said Kashmir Freedom Fighter (KFF), the proxy name of a terrorist outfit, claimed responsibility for the attack on Bhat. from Times of India https://ift.tt/Sk9sv5q via

Molnupiravir has serious safety concerns: ICMR chief

Antiviral drug molnupiravir, which recently got approval from the drug regulator and is being launched by several local drug makers, has serious safety concerns, and thus has not been included in the national Covid-19 clinical protocol recommended by the health ministry, the Indian Council of Medical Research (ICMR) director general Balram Bhargava said. from Times of India https://ift.tt/3pXmODT via